Pages that link to "Q59360930"
Jump to navigation
Jump to search
The following pages link to Drug Repurposing for Viral Infectious Diseases: How Far Are We? (Q59360930):
Displaying 24 items.
- Novel amodiaquine derivatives potently inhibit Ebola virus infection (Q58615350) (← links)
- A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents (Q58787671) (← links)
- Drug Repurposing for Japanese Encephalitis Virus Infection by Systems Biology Methods (Q60950235) (← links)
- Perspectives of Phage Therapy in Non-bacterial Infections (Q61449838) (← links)
- ReDO_DB: the repurposing drugs in oncology database (Q61450929) (← links)
- Development of Orthogonal Linear Separation Analysis (OLSA) to Decompose Drug Effects into Basic Components (Q61796719) (← links)
- Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors (Q63246281) (← links)
- Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy (Q63246314) (← links)
- Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" (Q64250537) (← links)
- Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria. (Q64967027) (← links)
- Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases (Q89633449) (← links)
- Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus (Q90456746) (← links)
- Clinical trials on drug repositioning for COVID-19 treatment (Q91636659) (← links)
- Drug repurposing for new, efficient, broad spectrum antivirals (Q91834255) (← links)
- Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner (Q91882654) (← links)
- COVID-19 and psoriasis : should we fear for patients treated with biologics? (Q92108291) (← links)
- Hepatitis E Virus Drug Development (Q92376567) (← links)
- Drug repositioning in cancer: The current situation in Japan (Q92763621) (← links)
- Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2? (Q93188504) (← links)
- Structural basis for RNA replication by the SARS-CoV-2 polymerase (Q95601567) (← links)
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication (Q98205148) (← links)
- Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges (Q98578804) (← links)
- Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach (Q99575411) (← links)
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients (Q107058845) (← links)